Search Results for "Pharmac Cost Of Sativex In New Zealand"

00:19 EST 24th January 2017 | BioPortfolio

Matching Channels

Marginal cost

TASH Biotechnology

Shanghai TASH Biotechnology Co.,Ltd. specializes in peptide development on the basis of high technology. TASH Biotechnology are focusing on custom peptide synthesis, and the research, development...


BAC’s CaptureSelect products are affinity ligands and affinity resins created by a proprietary technology based on Camelid-derived single domain antibody fragments for the purification of biop...


CombiCult® is an award winning, combinatorial screening technology that allows scientists to discover new and improved stem cell differentiation protocols. How Combicult® works A short o...

Latin America

Latin America encompasses the Caribbean, South America and Central America. These countries are important players in the biotechnology industry, not only as consumers, but as contributors. The env...

Matching News

NZ’s PHARMAC to list Praxbind and achieves price cut on Pradaxa

New Zealand’s Pharmaceutical Management Agency PHARMAC today announced the approval of an agreement…

PHARMAC update on proposed changes to anti-VEGF treatments for ophthalmic use

On September 25, 2016, New Zealand’s Pharmaceutical Management Agency PHARMAC consulted on a proposal…

PHARMAC funding for Roche and Pfizer drugs

New Zealand’s Pharmaceutical Management Agency PHARMAC has announce a major funding package following…

Decision relating to anti-VEGF treatments for ophthalmic use in New Zealand

New Zealand’s Pharmaceutical Management Agency PHARMAC consulted on a proposal to list ranibizumab…

New Zealand proposal to list HIV treatment Tivicay and amend Kivexa listing

New Zealand’s Pharmaceutical Management Agency PHARMAC is seeking feedback on a proposal to list a…

NZ to fund use of GlaxoSmithKline’s HIV drugs Kivexa and Tivicay

New Zealand’s Pharmaceutical Management Agency PHARMAC has reached agreement with the local subsidiary…

BRIEF-AFT Pharmaceuticals says request for proposal issued by PHARMAC

* RFP seeks proposals for either dual listing or sole supply of metoprolol in New Zealand with submission due date of 27 jan 2017

NZ’s PHARMAC to award sole supply to Zoladex from AstraZeneca

PHARMAC has made decisions to award the Zoladex brand of cancer drug goserelin Sole Subsidized Supply…

Matching PubMed Articles

Pacemaker Use in New Zealand - Data From the New Zealand Implanted Cardiac Device Registry (ANZACS-QI 15).

The New Zealand Cardiac Implanted Device Registry (Device) has recently been developed under the auspices of the New Zealand Branch of the Cardiac Society of Australia and New Zealand. This study desc...

Parental smoking during pregnancy: findings from the Growing Up in New Zealand cohort.

To investigate patterns of exposure to tobacco smoke in pregnancy among a representative sample of New Zealand women.

Burden of disease from second-hand smoke exposure in New Zealand.

To estimate the number of deaths and disability-adjusted life years (DALYs) attributable to secondhand smoke in New Zealand.

Traditional Chinese medicine practitioners in New Zealand: differences associated with being a practitioner in New Zealand compared to China.

While New Zealand has experienced an increase in the use of traditional Chinese medicine (TCM) based acupuncture, very little is known about the practitioners who provide this type of treatment modali...

The impact of the Hand Hygiene New Zealand programme on hand hygiene practices in New Zealand's public hospitals.

To detail the progress made by Hand Hygiene New Zealand (HHNZ) since 2011 and also describe the challenges experienced along the way and the factors required for delivery of a successful hand hygiene ...

Search Whole site using Google

Quick Search
Advertisement Advertisement